Cargando…
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration
PURPOSE: Azidothymidine (AZT), a nucleoside reverse transcriptase inhibitor, possesses anti-inflammatory and anti-angiogenic activity independent of its ability to inhibit reverse transcriptase. The aim of this study was to evaluate the efficacy of 5′-glucuronyl azidothymidine (GAZT), an antiretrovi...
Autores principales: | Narendran, Siddharth, Pereira, Felipe, Yerramothu, Praveen, Apicella, Ivana, Wang, Shao-bin, Varshney, Akhil, Baker, Kirstie L., Marion, Kenneth M., Ambati, Meenakshi, Ambati, Vidya L., Ambati, Kameshwari, Sadda, Srinivas R., Gelfand, Bradley D., Ambati, Jayakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441363/ https://www.ncbi.nlm.nih.gov/pubmed/32749462 http://dx.doi.org/10.1167/iovs.61.10.4 |
Ejemplares similares
-
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration
por: Narendran, Siddharth, et al.
Publicado: (2021) -
Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal Detachment
por: Huang, Peirong, et al.
Publicado: (2023) -
Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity
por: Fukuda, Shinichi, et al.
Publicado: (2021) -
Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
por: Wang, Shao-bin, et al.
Publicado: (2023) -
Reduction of human Alzheimer’s disease risk and reversal of mouse model cognitive deficit with nucleoside analog use
por: Magagnoli, Joseph, et al.
Publicado: (2023)